高风险肺栓塞需ECMO支持时的最佳再灌注策略:系统评价与荟萃分析
该系统评价与荟萃分析纳入17项研究共327例需ECMO支持的高风险肺栓塞患者,比较机械再灌注(主要为外科取栓)与其他策略的死亡和出血结局。机械再灌注组死亡率为22.6%,其他策略组为42.8%,机械再灌注的合并OR为0.439(95%CI 0.237-0.816)。出血率两组无显著差异(OR 1.27,95%CI 0.54-2.96)。
要点
- 需ECMO支持的高风险肺栓塞患者中,机械再灌注(尤其外科取栓)与较低死亡率相关。
- 机械再灌注与其他策略的出血风险无显著差异。
- ECMO植入时机、溶栓使用或心脏骤停表现不影响机械再灌注的获益。
核心结论
- 机械再灌注(尤其是外科取栓)可能改善需ECMO支持的高风险肺栓塞患者的死亡结局,且不受ECMO植入时机、溶栓使用或心脏骤停表现影响。
研究设计与样本
- 系统评价与荟萃分析,共纳入17项研究,327例需ECMO支持的高风险肺栓塞患者。
主要发现
- 机械再灌注组死亡率22.6%,其他策略组42.8%。
- 机械再灌注与其他策略相比死亡OR为0.439(95%CI 0.237-0.816;p=0.009;I2=35.2%)。
- 外科取栓与溶栓相比死亡OR为0.368(95%CI 0.185-0.733;p=0.004;I2=32.9%)。
- ECMO支持下出血率机械再灌注组22.2%,其他策略组19.1%(OR 1.27,95%CI 0.54-2.96;I2=7.7%)。
- 荟萃回归未发现「超过一种肺再灌注治疗」「肺再灌注前ECMO植入」「PE临床表现」或「癌症相关PE」与结局相关。
关键数值与推荐
- 机械再灌注组中85.9%接受外科取栓,32.4%接受机械肺再灌注,67.6%接受其他策略。
临床怎么用
- 对于需ECMO支持的高风险肺栓塞患者,可考虑优先选择机械再灌注(尤其是外科取栓)策略。
- ECMO植入时机、是否溶栓或是否心脏骤停不应作为排除机械再灌注的依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal pulmonary revascularisation strategy in high-risk pulmonary embolism (PE) requiring implantation of extracorporeal membrane oxygenation (ECMO) remains controversial. METHODS: We conducted a systematic review and meta-analysis of evidence comparing mechanical embolectomy and other strategies, including systemic thrombolysis, catheter-directed thrombolysis or ECMO as stand-alone therapy, with regard to mortality and bleeding outcomes. RESULTS: We identified 835 studies, 17 of which were included, comprising 327 PE patients. Overall, 32.4% were treated with mechanical pulmonary reperfusion (of whom 85.9% had surgical embolectomy), while 67.6% received other strategies. The mortality rate was 22.6% in the mechanical reperfusion group and 42.8% in the "other strategies" group. The pooled odds ratio for mortality with mechanical reperfusion was 0.439 (95% CI 0.237-0.816) (p=0.009; I2=35.2%) versus other reperfusion strategies and 0.368 (95% CI 0.185-0.733) (p=0.004; I2=32.9%) for surgical embolectomy versus thrombolysis. The rate of bleeding in patients under ECMO was 22.2% in the mechanical reperfusion group and 19.1% in the "other strategies" group (OR 1.27, 95% CI 0.54-2.96; I2=7.7%). The meta-regression model did not identify any relationship between the covariates "more than one pulmonary reperfusion therapy", "ECMO implantation before pulmonary reperfusion therapy", "clinical presentation of PE" or "cancer-associated PE" and the associated outcomes. CONCLUSIONS: The results of the present meta-analysis and meta-regression suggest that mechanical reperfusion, notably by surgical embolectomy, may yield favourable results regardless of the timing of ECMO implantation in the reperfusion timeline, independent of thrombolysis administration or cardiac arrest presentation.
引用
- Chopard R, Nielsen P, Ius F, et al. Optimal reperfusion strategy in acute high-risk pulmonary embolism requiring extracorporeal membrane oxygenation support: a systematic review and meta-analysis. Eur Respir J. 2022. PMID: 35487534. doi:10.1183/13993003.02977-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。